FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 05/08/2014 |
3. Issuer Name and Ticker or Trading Symbol
Alcentra Capital Corp [ ABDC ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 1,450,999 | I | See footnotes(1)(2) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. On May 8, 2014, 6,100,000 shares of Alcentra Capital Corporation's common stock were held directly by BNY Mellon-Alcentra Mezzanine III, L.P. ("Fund III"), including the 1,450,999 shares hereby reported. On December 31, 2014, Fund III distributed the 6,100,000 shares to its limited partners, including Alcentra Investments Limited, on a pro-rata basis. Alcentra Investments Limited has a 23.79% limited partnership interest in Fund III, and after the pro-rata distribution, became the direct holder of the 1,450,999 shares hereby reported. Entities controlled by BNY Alcentra Group Holdings, Inc. and The Bank of New York Mellon Corporation are the direct and indirect parent companies of Alcentra Investments Limited and act as the general partner and investment manager to Fund III. |
2. At May 8, 2014, Alcentra Investments Limited, BNY Alcentra Group Holdings, Inc. and The Bank of New York Mellon Corporations are indirect beneficial owners of the reported securities. As of December 31, 2014, Alcentra Investments Limited is the direct holder of the reported securities, and BNY Alcentra Group Holdings, Inc. and The Bank of New York Mellon Corporation are indirect beneficial owners of the reported securities. |
/s/ Mitchell E. Harris | 01/07/2015 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |